About EDGAR Online | Login
 
The following is an excerpt from a 10-Q SEC Filing, filed by MYLAN LABORATORIES INC on 2/14/2001.
Next Section Next Section Previous Section Previous Section
MYLAN INC. - 10-Q - 20010214 - CASH_FLOW

MYLAN LABORATORIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE NINE MONTHS ENDED DECEMBER 31, 2000, AND 1999

(In thousands)

                                    Unaudited

                                                           2000        1999
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) earnings                                     $ (4,935)  $ 109,453
Adjustments to reconcile net (loss) earnings to net
cash provided from operating activities:
    Depreciation and amortization                         30,965      27,339
    Loss on disposal/sale of equipment                       363         186
    Deferred income tax benefit                          (25,848)    (13,303)
    Equity in the loss of Somerset                           751       2,619
    Cash received from Somerset                              308         335
    Allowances on accounts receivable                     22,704      32,160
    Deposit - litigation settlement                     (100,000)        -
    Litigation settlement                                147,000         -
    Other noncash (income) expenses                       (6,222)      7,225
Changes in operating assets and liabilities:

    Accounts receivable                                  (32,118)    (45,901)
    Inventories                                          (32,574)     (3,669)
    Trade accounts payable                                20,074       4,727
    Income taxes payable                                  12,767      11,853
    Other operating assets and liabilities                  (174)     (8,679)
                                                        ---------   ---------
Net cash provided from operating activities               33,061     124,345

CASH FLOWS FROM INVESTING ACTIVITIES:
  Additions to property, plant and equipment             (19,783)    (21,768)
  Decrease (increase) in intangible and other assets      37,568     (11,963)
  Proceeds from investment securities                    117,360     112,630
  Purchase of investment securities                      (55,755)   (135,967)
                                                         --------   ---------
Net cash provided from (used in) investing activities     79,390     (57,068)

CASH FLOWS FROM FINANCING ACTIVITIES:
  Payments on long-term obligations                       (1,390)     (6,186)
  Cash dividends paid                                    (15,151)    (15,494)
  Repurchase of common stock                             (91,456)          -
  Proceeds from exercise of stock options                  4,450       2,082
                                                        ---------    --------
Net cash used in financing activities                   (103,547)    (19,598)
                                                        ---------    --------
Net increase in cash and cash equivalents                  8,904      47,679
Cash and cash equivalents - beginning of period          203,493     189,849
                                                        ========    =========

Cash and cash equivalents - end of period             $  212,397    $237,528
                                                      ==========   ==========

CASH PAID DURING THE PERIOD FOR:
Interest                                              $      198    $    646
                                                      ==========   ==========
Income taxes                                          $   10,306    $ 64,167
                                                      ==========   ==========